Comparable Polyfunctionality of Ectromelia Virus- and Vaccinia Virus-Specific Murine T Cells despite Markedly Different In Vivo Replication and Pathogenicity

ABSTRACT Vaccinia virus (VACV) stimulates long-term immunity against highly pathogenic orthopoxvirus infection of humans (smallpox) and mice (mousepox [ectromelia virus {ECTV}]) despite the lack of a natural host-pathogen relationship with either of these species. Previous research revealed that VACV is able to induce polyfunctional CD8+ T-cell responses after immunization of humans. However, the degree to which the functional profile of T cells induced by VACV is similar to that generated during natural poxvirus infection remains unknown. In this study, we monitored virus-specific T-cell responses following the dermal infection of C57BL/6 mice with ECTV or VACV. Using polychromatic flow cytometry, we measured levels of degranulation, cytokine expression (gamma interferon [IFN-γ], tumor necrosis factor alpha [TNF-α], and interleukin-2 [IL-2]), and the cytolytic mediator granzyme B. We observed that the functional capacities of T cells induced by VACV and ECTV were of a similar quality in spite of the markedly different replication abilities and pathogenic outcomes of these viruses. In general, a significant fraction (≥50%) of all T-cell responses were positive for at least three functions both during acute infection and into the memory phase. In vivo killing assays revealed that CD8+ T cells specific for both viruses were equally cytolytic (∼80% target cell lysis after 4 h), consistent with the similar levels of granzyme B and degranulation detected among these cells. Collectively, these data provide a mechanism to explain the ability of VACV to induce protective T-cell responses against pathogenic poxviruses in their natural hosts and provide further support for the use of VACV as a vaccine platform able to induce polyfunctional T cells.

[1]  J. Marchal Infectious Ectromelia. A hitherto Undescribed Virus Disease of Mice. , 1930 .

[2]  An Unsuspected Relationship between the Viruses of Vaccinia and Infectious Ectromelia of Mice , 1945, Nature.

[3]  F. Burnet,et al.  The relationship between the virus of infectious ectromelia of mice and vaccinia virus. , 1946, Journal of immunology.

[4]  F. Fenner,et al.  Studies in infectious ectromelia of mice; immunization of mice against ectromelia with living vaccinia virus. , 1947, The Australian journal of experimental biology and medical science.

[5]  F. Fenner Studies in infectious ectromelia in mice; natural transmission; the portal of entry of the virus. , 1947, The Australian journal of experimental biology and medical science.

[6]  F. Fenner,et al.  The pathogenesis of the acute exanthems; an interpretation based on experimental investigations with mousepox; infectious ectromelia of mice. , 1948, Lancet.

[7]  F. Fenner,et al.  Mouse-pox; infectious ectromelia of mice; a review. , 1949, Journal of immunology.

[8]  R. Blanden MECHANISMS OF RECOVERY FROM A GENERALIZED VIRAL INFECTION: MOUSEPOX , 1971, The Journal of experimental medicine.

[9]  U. Kees,et al.  A single genetic element in H-2K affects mouse T-cell antiviral function in poxvirus infection , 1976, The Journal of experimental medicine.

[10]  R. Herberman,et al.  Lymphocyte-mediated cytotoxicity. , 1987, Pediatric annals.

[11]  R. Jacoby,et al.  Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. I. Clinical responses. , 1987, Laboratory animal science.

[12]  J. Ro,et al.  Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. II. Pathogenesis. , 1987 .

[13]  P. Morrissey,et al.  Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Karupiah,et al.  Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection , 1996, Journal of virology.

[15]  K. Ebnet,et al.  Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Peschon,et al.  Antiviral Activity of Tumor Necrosis Factor (TNF) Is Mediated via p55 and p75 TNF Receptors , 1997, The Journal of experimental medicine.

[17]  M. Simon,et al.  Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Tscharke,et al.  A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. , 1999, The Journal of general virology.

[19]  M. Simon,et al.  Perforin Is Essential for Control of Ectromelia Virus but Not Related Poxviruses in Mice , 1999, Journal of Virology.

[20]  D A Henderson,et al.  Diagnosis and management of smallpox. , 2002, The New England journal of medicine.

[21]  D. Tscharke,et al.  A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence. , 2002, The Journal of general virology.

[22]  D. Tscharke,et al.  A study of the vaccinia virus interferon-γ receptor and its contribution to virus virulence , 2002 .

[23]  R. Koup,et al.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.

[24]  A. Müllbacher Cell‐mediated cytotoxicity in recovery from poxvirus infections , 2003, Reviews in medical virology.

[25]  Rustom Antia,et al.  Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.

[26]  G. Karupiah,et al.  Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Kellam,et al.  Poxvirus genomes: a phylogenetic analysis. , 2004, The Journal of general virology.

[28]  L. Sigal,et al.  Antibodies and CD8+ T Cells Are Complementary and Essential for Natural Resistance to a Highly Lethal Cytopathic Virus1 , 2005, The Journal of Immunology.

[29]  R. Buller,et al.  Ectromelia virus: the causative agent of mousepox. , 2005, The Journal of general virology.

[30]  D. Tscharke,et al.  Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines , 2005, The Journal of experimental medicine.

[31]  Laurie Lamoreaux,et al.  Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. , 2006, Journal of immunological methods.

[32]  Mario Roederer,et al.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.

[33]  Magdalini Moutaftsi,et al.  A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus , 2006, Nature Biotechnology.

[34]  P. Mortimer,et al.  Classic paper: Fenner on the exanthemata† , 2006, Reviews in medical virology.

[35]  G. Karupiah,et al.  Protective Immunity against Secondary Poxvirus Infection Is Dependent on Antibody but Not on CD4 or CD8 T-Cell Function , 2006, Journal of Virology.

[36]  L. Sigal,et al.  Direct CD28 Costimulation Is Required for CD8+ T Cell-Mediated Resistance to an Acute Viral Disease in a Natural Host1 , 2006, The Journal of Immunology.

[37]  G. Karupiah,et al.  Obligatory Requirement for Antibody in Recovery from a Primary Poxvirus Infection , 2006, Journal of Virology.

[38]  Jason A. Skinner,et al.  Bordetella bronchiseptica Modulates Macrophage Phenotype Leading to the Inhibition of CD4+ T Cell Proliferation and the Initiation of a Th17 Immune Response1 , 2006, The Journal of Immunology.

[39]  Mario Roederer,et al.  Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses , 2007, The Journal of experimental medicine.

[40]  Magdalini Moutaftsi,et al.  Vaccinia Virus-Specific CD4+ T Cell Responses Target a Set of Antigens Largely Distinct from Those Targeted by CD8+ T Cell Responses1 , 2007, The Journal of Immunology.

[41]  J. Lieberman,et al.  Delivering the kiss of death: progress on understanding how perforin works. , 2007, Current opinion in immunology.

[42]  A. Klein-Szanto,et al.  Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection , 2007, Proceedings of the National Academy of Sciences.

[43]  Mario Roederer,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.

[44]  G. Karupiah,et al.  Correlates of protective immunity in poxvirus infection: where does antibody stand? , 2008, Immunology and cell biology.

[45]  J. Yewdell,et al.  Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes , 2008, Nature Immunology.

[46]  S. McCormack,et al.  An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses , 2008, The Journal of experimental medicine.

[47]  M. Roederer,et al.  T-cell quality in memory and protection: implications for vaccine design , 2008, Nature Reviews Immunology.

[48]  Mario Roederer,et al.  Frontline : Polyfunctional T cell responses are a hallmark of HIV-2 infection , 2008 .

[49]  J. Orange,et al.  Rapid Up-Regulation and Granule-Independent Transport of Perforin to the Immunological Synapse Define a Novel Mechanism of Antigen-Specific CD8+ T Cell Cytotoxic Activity1 , 2009, The Journal of Immunology.

[50]  E. Kroon,et al.  Natural human infections with Vaccinia virus during bovine vaccinia outbreaks. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[51]  E. Kroon,et al.  One More Piece in the VACV Ecological Puzzle: Could Peridomestic Rodents Be the Link between Wildlife and Bovine Vaccinia Outbreaks in Brazil? , 2009, PloS one.

[52]  C. Sorzano,et al.  Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions , 2010, PloS one.

[53]  Studying NK cell responses to ectromelia virus infections in mice. , 2010, Methods in molecular biology.

[54]  D. Dolfi,et al.  Perforin and IL-2 Upregulation Define Qualitative Differences among Highly Functional Virus-Specific Human CD8+ T Cells , 2010, PLoS pathogens.

[55]  F. Pereyra,et al.  Perforin Expression Directly Ex Vivo by HIV-Specific CD8+ T-Cells Is a Correlate of HIV Elite Control , 2010, PLoS pathogens.

[56]  Felipe García,et al.  The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens , 2011, Journal of Virology.